Efficacy of levosimendan in Takotsubo-related cardiogenic shock

被引：18
|
作者：
Antonini, M. [1 ]
Stazi, G. V. [1 ]
Cirasa, M. T. [1 ]
Garotto, G. [1 ]
Frustaci, A. [1 ]
机构：
[1] Crit Care Unit INMI L Spallanzani, I-00149 Rome, Italy
来源：
ACTA ANAESTHESIOLOGICA SCANDINAVICA | 2010年 / 54卷 / 01期
关键词：
APICAL BALLOONING SYNDROME;
D O I：
10.1111/j.1399-6576.2009.02105.x
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [21] Levosimendan, a Promising Pharmacotherapy in Cardiogenic Shock: A Comprehensive Review
    Susilo, Hendri
    Aldian, Fan Maitri
    Wungu, Citrawati Dyah Kencono
    Alsagaff, Mochamad Yusuf
    Sutanto, Henry
    Multazam, Chaq El Chaq Zamzam
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [22] Cardiogenic shock in takotsubo syndrome: etiology and treatment
    Kato, Ken
    Di Vece, Davide
    Kitagawa, Mari
    Yamamoto, Kayo
    Aoki, Shuhei
    Goto, Hiroki
    Kitahara, Hideki
    Kobayashi, Yoshio
    Templin, Christian
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2024, 39 (04) : 421 - 427
  • [23] Immunomodulatory effects of levosimendan in vitro and in patients with cardiogenic shock
    Hasslacher, Julia
    Dunzendorfer, Stefan
    Bellmann, Romuald
    Joannidis, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A29 - A29
  • [24] Treatment of cardiogenic shock with levosimendan in combination with β-adrenergic antagonists
    Alhashemi, JA
    BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (05) : 648 - 650
  • [25] Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock
    Guarracino, F.
    Landoni, G.
    Baldassarri, R.
    Nobile, L.
    Stefani, M.
    BRITISH JOURNAL OF ANAESTHESIA, 2010, 104 (03) : 388 - 389
  • [26] Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning
    Zeitouni, M.
    Dorvillius, E.
    Sulman, D.
    Procopi, N.
    Beaupre, F.
    Devos, P.
    Barthelemy, O.
    Rouanet, S.
    Ferrante, A.
    Chommeloux, J.
    Hekimian, G.
    Kerneis, M.
    Silvain, J.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning
    Zeitouni, M.
    Dorvillius, E.
    Sulman, D.
    Procopi, N.
    Beaupre, F.
    Devos, P.
    Barthelemy, O.
    Rouanet, S.
    Ferrante, A.
    Chommeloux, J.
    Hekimian, G.
    Kerneis, M.
    Silvain, J.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [28] Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning
    Zeitouni, Michel
    Dorvillius, Elodie
    Sulman, David
    Procopi, Niki
    Beaupre, Frederic
    Devos, Perrine
    Barthelemy, Olivier
    Rouanet, Stephanie
    Ferrante, Arnaud
    Chommeloux, Juliette
    Hekimian, Guillaume
    Kerneis, Mathieu
    Silvain, Johanne
    Montalescot, Gilles
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 249 - 258
  • [29] Levosimendan in cardiogenic shock: The magic drug for every patient?
    Smetana, Peter
    Geppert, Alexander
    CRITICAL CARE MEDICINE, 2007, 35 (12) : 2862 - 2864
  • [30] Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock
    Omerovic, E.
    Ramunddal, T.
    Albertsson, P.
    Matejka, G.
    EUROPEAN HEART JOURNAL, 2007, 28 : 813 - 813
12345